Cite
HARVARD Citation
Reilmann, R. et al. (n.d.). J05 Legato-hd study: a phase 2 study assessing the efficacy and safety of laquinimod as a treatment for huntington disease. Journal of neurology, neurosurgery and psychiatry. p. A99. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Reilmann, R. et al. (n.d.). J05 Legato-hd study: a phase 2 study assessing the efficacy and safety of laquinimod as a treatment for huntington disease. Journal of neurology, neurosurgery and psychiatry. p. A99. [Online].